In short
Diagnosing osteonecrosis of the jaw requires careful examination by dental and medical professionals, as early detection can make a significant difference in managing this rare but serious condition.
Key points
- Visual examination and x-rays are the primary tools for diagnosing ONJ, with exposed bone persisting for more than eight weeks being the key diagnostic sign
- There is no blood test to diagnose ONJ, making regular dental check-ups essential for people taking bone-modifying medications
- The jawbone is uniquely vulnerable because it regenerates frequently and teeth create a direct pathway for potential problems
- ONJ affects about 2 out of 100 cancer patients receiving intravenous bisphosphonates, but less than 0.1% of people taking lower doses for osteoporosis
- Healthcare providers use staging systems to classify ONJ from Stage 0 (no visible bone exposure) to Stage 3 (extensive bone involvement)
- Some people with ONJ have no symptoms at all, making routine dental monitoring critical for early detection
- The mandible (lower jaw) is more commonly affected than the maxilla (upper jaw)
- Distinguishing ONJ from bone infection is important, as osteomyelitis typically causes fever while ONJ does not
Introduction: Who Should Undergo Diagnostics
If you are taking certain medications for bone health or cancer treatment, or if you notice unusual changes in your mouth after dental work, it is important to seek diagnostic evaluation. Osteonecrosis of the jaw (ONJ) is a condition where the bone in your jaw dies and becomes exposed through your gums, and catching it early can help prevent more serious complications.
You should consider seeking diagnostics if you develop symptoms such as jaw pain, loose teeth, mouth sores that do not heal, swollen gums, or discharge in your mouth. These signs may appear after dental procedures like tooth extractions, or they can occur without any obvious trigger. Some people do not experience any symptoms at all in the early stages, which is why regular dental check-ups are particularly important for people at higher risk.
People who receive intravenous medications called bisphosphonates for cancer treatment are at the highest risk for developing ONJ. These medications help strengthen bones and reduce bone pain caused by cancer that has spread to the bones. The risk affects approximately 2 out of every 100 people with cancer who receive these medications. People taking lower doses of bone-strengthening drugs for osteoporosis (a condition where bones become weak and brittle) have a much lower risk, but they should still remain aware of the possibility.
Seeking diagnostics promptly is advisable if you have recently had oral surgery such as tooth removal, dental implants, or bone grafts, especially if you are taking medications that affect bone health. The condition tends to develop after such procedures because the gum tissue may not heal properly, leaving the jawbone exposed and vulnerable to damage.
Diagnostic Methods
Diagnosing osteonecrosis of the jaw begins with a thorough visual examination of your mouth. Your dentist or oral surgeon will look for signs of exposed bone, areas where the gum tissue has not healed, or other abnormalities in the soft tissues surrounding your teeth and jawbone. The presence of exposed bone that lasts for more than eight weeks is a key sign that helps healthcare providers identify ONJ.
During the examination, your healthcare provider will ask about your medical history, particularly whether you are taking or have previously taken medications that affect bone health. This includes bisphosphonates such as alendronate (Fosamax), risedronate (Actonel), ibandronate (Boniva), and zoledronic acid (Zometa or Reclast), as well as denosumab (Prolia or Xgeva). They will also want to know if you have received chemotherapy, radiation therapy to the head or neck, or long-term steroid treatment, as these can increase your risk.
X-rays are an important part of the diagnostic process. Your dentist may take dental x-rays to check for changes in the bone structure that are not visible during a visual examination. These images can reveal areas where the bone is weakening or dying, even before it becomes exposed through the gums. X-rays help your healthcare team understand the extent of the problem and plan the most appropriate treatment.
In some cases, more advanced imaging may be needed to fully assess the condition. While standard x-rays are usually sufficient for initial diagnosis, healthcare providers may use additional imaging techniques to get a clearer picture of how much bone is affected and whether the condition has spread to nearby areas. This information is important because it helps determine the stage of the disease and guides treatment decisions.
Your healthcare provider will also assess your symptoms carefully. They will ask about jaw pain, whether you have noticed any loose teeth, if there is numbness or a heavy feeling in your jaw, whether you have bad breath, and if you have noticed any pus-like discharge or drainage in your mouth. Not everyone with ONJ experiences pain, so the absence of symptoms does not rule out the condition. This is why the visual examination and imaging are so important.
It is important to distinguish ONJ from other conditions that can cause similar symptoms. Osteomyelitis is a bone infection caused by bacteria or fungi that can affect the jawbone and produce symptoms that look like ONJ. However, osteomyelitis usually causes fever, which ONJ does not. Healthcare providers can use blood tests to check for signs of infection and help determine whether the problem is ONJ or osteomyelitis.
Another related condition is osteoradionecrosis, which occurs in people who have received radiation therapy for head and neck cancers. This condition develops when radiation destroys the blood vessels that carry blood to the bones in the jaw, causing bone death. Osteoradionecrosis affects approximately 3% to 10% of people who receive such radiation treatment. The key difference is the history of radiation exposure, which your healthcare provider will explore during diagnosis.
The diagnosis is confirmed when exposed bone in the jaw persists for at least eight weeks, and the patient has a current or previous history of taking medications that affect bone health, without a history of radiation therapy or cancer spreading to the jaws. This definition helps ensure that the condition is accurately identified and not confused with other diseases.
Staging the condition is an important part of the diagnostic process. Healthcare providers commonly use a system that classifies ONJ into different stages based on the severity of symptoms and the extent of bone exposure. Stage 0 means you are taking the medication and have nonspecific jaw pain, but no dead bone is detected. Stage 1 means there is exposed dead bone but little to no pain. Stage 2 indicates exposed dead bone that is infected and painful. Stage 3 means the dead bone has spread beyond the area adjacent to your teeth. Understanding the stage helps your healthcare team decide on the best treatment approach.
Diagnostics for Clinical Trial Qualification
While the sources provided do not contain specific information about diagnostic tests or methods used as standard criteria for enrolling patients in clinical trials related to osteonecrosis of the jaw, clinical trials in general would likely require the same basic diagnostic procedures described above to confirm the presence and stage of the condition. Participants would need a confirmed diagnosis through visual examination, x-rays or other imaging, and a documented medical history including current or past use of bone-modifying medications. The staging of the disease would also be important for determining eligibility for different types of clinical trials.
